Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
about
Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphomaClinical and biological aspects of acid phosphatasePhase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies.T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes.Interferons regulate the in vitro differentiation of multilineage lympho-myeloid stem cells in hairy cell leukemiaThe molecular genetics of hematologic malignanciesPhenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells.Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 casesSoluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.Expression of interleukin 2 receptors on activated human B cellsBoth interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell functionGrowth factor-mediated tumor cell proliferation in hairy cell leukemia.Evolving concepts in the pathogenesis of hairy-cell leukaemia.Treating multiple sclerosis with monoclonal antibodies.Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA.44 and other antibodiesRetrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage.B-cell monoclonal antibodies and their use in clinical oncology.Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia.Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies.Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages.The soluble interleukin-2 receptor in haematological disorders.Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.Alpha interferons in B-cell neoplasms.Interferon alpha and intracytoplasmic free calcium in hairy cell leukemia cells.The interleukin-2 receptor: a target for immunotherapy.Cell surface antigens in leukemias and lymphomas.Atypical prolymphocytic variant of hairy-cell leukemia: case report and review of the literature.Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin.Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.Hairy cell leukemia: 1986Biological significance of soluble IL-2 receptor.
P2860
Q24563775-8AAEA602-03C0-41EB-B2E6-123DCF5A5B33Q28290423-3F4636E0-CC2F-4C8C-9010-83E919E93CD6Q33491097-694ED1D1-714A-4FB4-BEA1-4E2328CBF803Q34334887-F54BB3EF-FF75-42C2-8BC0-32F45E9C732FQ34540698-02E93662-AC60-4812-9ADD-5A2BA27F535EQ34613272-D1537CFD-2B4E-4E08-8780-90ED889AD524Q35224361-1BADC59A-F1DD-41BE-8602-F49195279B6BQ35835650-ABD6375B-E91B-413E-9C9F-9FE9FB2B82EAQ35855947-7309805A-7E73-413A-A7A3-F16F63A90DBFQ36027945-AEE86912-9E23-4A5D-A4E3-8C14F3CC4B27Q36349541-23965E37-007A-498B-B080-904A7DBADC6FQ36349546-D027E11C-2CB0-47E0-9469-D8AE415DC640Q36349561-6E69C4F4-F5AD-4723-BC08-B9346C7AE5D0Q36349713-A89C4685-2CC4-4FA6-B50E-867901827212Q36349791-9F1ADD92-9FD6-40F4-91C7-1EFB52DB17A5Q36350795-4BFC785C-AE70-46D3-B1E4-2FEAA441B590Q36488725-F376D0C4-7FC0-4B49-85F8-A1CFFB05A14EQ37111904-108A7C25-112D-4D1D-8D17-97D87F932648Q37186185-D59F4352-C666-434E-AD5F-724ED04C6A97Q37253748-6D0381BD-F591-4855-8988-3CFBB3046FAEQ37578856-E2D8A4B0-673A-40C8-9D8D-8285B0D722B5Q37686904-06CB4F86-1AF7-4DA0-BC0C-718D24B0B16CQ37816419-D8EA059D-9053-4038-A86D-7B61066FB471Q37857872-A2553B2C-A551-4497-BEC5-4CDFB9EE42E7Q37889776-72E619BD-AD9E-4BD7-B062-DC521582F173Q38908200-8BD1C012-D0B9-4954-AC99-A338EFD388A8Q39549531-236FCF9F-00F8-4E6D-9B04-F31F32D2DF28Q39552174-594473BB-BFC6-480D-8656-B628F25405A7Q39599746-4123BD87-39A7-4E3F-9FC2-BFBE9ABB7CD4Q39729253-1966F186-3906-4585-8F64-9C9BF0B0F4E9Q39754076-AFD8DA0E-3FB8-4E49-AA69-689461D3DA18Q40751335-976BA1EA-D5CC-4EC9-84B3-093BDDFE7D83Q40841546-110B8931-DF47-46E8-AE3E-3A90AF43D5DEQ40986836-BF7839CC-3196-4F1F-9B1C-23FFDDAD63C0Q41189240-5397647A-C03D-4D72-8603-93A5D127B8BBQ41331795-64A412AF-259C-4F5C-916B-7D2432682537Q41734714-7C6FB3D0-08D0-486E-B1DA-08770F896102Q41756677-D7EBBE41-4A07-4D9F-9DEE-CC75F2E6604DQ41836688-29926DA6-E5EA-452B-901B-6FF521A3BEC5Q42106899-E6F13A2F-AD7C-4C53-AC17-E922279A9487
P2860
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@en
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@nl
type
label
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@en
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@nl
prefLabel
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@en
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@nl
P2093
P2860
P356
P1476
Rearrangement and expression o ...... ntigen in hairy cell leukemia.
@en
P2093
Korsmeyer SJ
Leonard WJ
Marshall SL
P2860
P304
P356
10.1073/PNAS.80.14.4522
P407
P577
1983-07-01T00:00:00Z